Form 4 for OFIX Orthofix Medical Inc.
Accepted 2022-06-08 00:00:00 ET · period of report 2022-06-06 · accession 0001209191-22-035049 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-06-08 | 2022-06-06 | OFIX | BURZIK CATHERINE M | Dir | A - Grant | $0.00 | +8,844 | 17.4K | +103% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-06 | A | A | 8,844 | $0.00 | 17,443 | D | — | — | (F1) Deferred stock unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction, pursuant to Rule 16(b)-3(d) under the Securities Exchange Act of 1934, as amended. The award vest in full on the first anniversary of the grant date, June 6, 2022. |